TuHURA BIOSCIENCES, INC./NV Other Nonoperating Income (Expense)
TuHURA BIOSCIENCES, INC./NV (HURA) reported Other Nonoperating Income (Expense) of -$460.01 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-14
- TuHURA BIOSCIENCES, INC./NV other nonoperating income (expense) for the quarter ending 2026-06-30 was -$460.01K, a 230.64% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV other nonoperating income (expense) for the quarter ending 2026-03-31 was -$6.70K, a 101.90% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV other nonoperating income (expense) for the quarter ending 2025-12-31 was $1.41M.
- TuHURA BIOSCIENCES, INC./NV other nonoperating income (expense) for the quarter ending 2025-09-30 was -$372.85K.
- TuHURA BIOSCIENCES, INC./NV other nonoperating income (expense) for fiscal 2025 was $1.74M.
- TuHURA BIOSCIENCES, INC./NV other nonoperating income (expense) for fiscal 2024 was -$4.03M, a 1000.39% decline from fiscal 2023.
- TuHURA BIOSCIENCES, INC./NV other nonoperating income (expense) for fiscal 2023 was $447.89K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$460.01K 10-Q · filed 2026-08-14 | -$466.71K 10-Q · filed 2026-08-14 | $945.33K derived: sum of 3 quarters · filed 2026-08-14 | $572.48K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$6.70K 10-Q · filed 2026-05-15 | $1.41M derived: sum of 2 quarters · filed 2026-05-15 | $1.03M derived: sum of 3 quarters · filed 2026-05-15 | $1.38M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.04M derived: sum of 2 quarters · filed 2026-03-31 | $1.39M derived: sum of 3 quarters · filed 2026-08-14 | $1.74M 10-K · filed 2026-03-31 |
| 2025-09-30 | -$372.85K 10-Q · filed 2025-11-14 | -$20.73K derived: sum of 2 quarters · filed 2026-08-14 | $331.92K 10-Q · filed 2025-11-14 | $30.90K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $352.12K 10-Q · filed 2026-08-14 | $704.77K 10-Q · filed 2026-08-14 | $403.75K derived: sum of 3 quarters · filed 2026-08-14 | -$1.45M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $352.65K 10-Q · filed 2026-05-15 | $51.63K derived: sum of 2 quarters · filed 2026-05-15 | -$1.80M derived: sum of 3 quarters · filed 2026-05-15 | -$3.44M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$301.02K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$2.15M derived: sum of 2 quarters · filed 2026-03-31 | -$3.80M derived: sum of 3 quarters · filed 2026-03-31 | -$4.03M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$1.85M 10-Q · filed 2025-11-14 | -$3.50M derived: sum of 2 quarters · filed 2025-11-14 | -$3.73M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$1.65M 10-Q · filed 2025-08-14 | -$1.88M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | -$236.39K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $447.89K 10-K · filed 2025-03-31 | |||
| 2017-03-31 | $84.23K 10-Q · filed 2017-05-12 | -$45.02K 10-Q · filed 2017-05-12 | ||
| 2016-03-31 | -$280.15K 10-Q · filed 2017-05-12 | $1.23M 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |